More about Vijaya Diagnostic Centre Limited
Fundamentals for Vijaya Diagnostic Centre Limited
Regulatory Filings for Vijaya Diagnostic Centre Limited
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
Fundamentals for Vijaya Diagnostic Centre Limited
Business Operations:
Sector: HealthcareIndustry: Diagnostics & Research
Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Revenue projections:
Vijaya Diagnostic Centre Limited's revenue is projected to decrease from last year, a development that could lead investors to adopt a more cautious approach. A revenue decline can negatively affect profitability, signaling challenges for the company and making it less attractive for those seeking solid financial performance.
Financial Ratios:
| currentRatio | 0.00000 |
|---|---|
| forwardPE | 48.18182 |
| debtToEquity | 42.22400 |
| earningsGrowth | 0.22500 |
| revenueGrowth | 0.21400 |
| grossMargins | 0.84993 |
| operatingMargins | 0.30074 |
| trailingEps | 16.75000 |
| forwardEps | 26.18000 |
VIJAYA's positive earnings and revenue growth signal that the company is expected to expand its business. This healthy financial trend reflects an optimistic outlook, suggesting continued growth in both sales and profits for VIJAYA.
VIJAYA's positive gross and operating margins highlight its strong profitability. The company's ability to control costs while generating revenue indicates efficient operations and a healthy financial position.
With a forward EPS greater than its trailing EPS, VIJAYA is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.
Price projections:
VIJAYA's price has consistently hovered around the lower end of analysts' projections. This pattern may reflect concerns regarding the company's ability to achieve its anticipated growth.
Recommendation changes over time:
A recent buy bias from analysts toward VIJAYA indicates strong confidence in the stock's future performance. This could encourage investors to park their money in VIJAYA, viewing it as a stable and potentially rewarding investment opportunity with promising long-term growth prospects.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
How Independent Directors Failed Rs 2,500 Crore in Value
India’s Stock Market May Be Sitting on a Trap